ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colonic Cancer
Colorectal Cancer
Cancer
Rectal Cancer
Neoplasm Metastasis
Pancreatic Cancer
Non-Small-Cell Lung Carcinoma

Colon Cancer trials near Berlin, BE, DEU:

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: CAPEOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Berlin, Germany and 262 other locations

and bevacizumab in terms of overall response rate for patients with HER-2 positive metastatic/locally advanced unresectable colorectal cancer...

Enrolling
Colon Cancer Metastatic
Rectal Cancer, Adenocarcinoma
Drug: Bevacizumab
Drug: Capecitabine

Phase 2

Gruppo Oncologico del Nord-Ovest

Berlin, Germany and 27 other locations

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon...

Enrolling
Intestinal Neoplasms
Neoplasms by Site
Biological: Bevacizumab
Drug: Chemotherapy

Phase 3

Pfizer
Pfizer

Berlin, Germany and 155 other locations

Locations recently updated

chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer....

Enrolling
CRC (Colorectal Cancer)
Drug: INCA33890
Drug: Placebo

Phase 3

Incyte
Incyte

Berlin, Germany and 275 other locations

in each subject population expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. The seco...

Enrolling
Locally Advanced Solid Tumors
Metastatic Solid Tumors
Drug: Oral repotrectinib (TPX-0005)

Phase 1, Phase 2

Turning Point Therapeutics
Turning Point Therapeutics

Berlin, Germany and 163 other locations

Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...

Active, not recruiting
Metastatic Colorectal Cancer
Advanced Colorectal Cancer
Drug: MRTX849
Biological: Cetuximab

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Berlin, Germany and 427 other locations

with standard chemotherapy for the potential treatment of colorectal cancer that:* has spread to other parts of the body (metastatic);* has ...

Active, not recruiting
Neoplasms
Drug: Cetuximab
Drug: Oxaliplatin

Phase 3

Pfizer
Pfizer

Berlin, Germany and 269 other locations

of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer...

Active, not recruiting
Colorectal Cancer Stage III
Colorectal Cancer Stage II
Drug: RO7198457 intravenous (IV)
Other: Observational group (no intervention)

Phase 2

BioNTech
BioNTech

Berlin, Germany and 92 other locations

The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bev...

Active, not recruiting
Metastatic Colorectal Cancer
Biological: Bevacizumab experimental
Drug: Capecitabine

Phase 3

Servier
Servier

Berlin, Germany and 189 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems